Abstract

ROSSETTI, María Victoria et al. Heme metabolism: the janus nature of precursorsand porphyrins. Acta bioquím. clín. latinoam. [online]. 2016, vol.50, n.4, pp.547-573. ISSN 0325-2957.

Porphyrias comprise a group of metabolic disorders of the heme biosynthesis pathway resulting in a specific accumulation and excretion of intermediates which are responsible for their pathophysiology. Acute porphyrias are characterized by acute neurovisceral symptoms due to the overproduction and accumulation of d-aminolevulinic acid (ALA) which leads to an oxidative damage resulting from the formation of reactive oxygen species (ROS). In cutaneous porphyrias, the symptomatology is a result of porphyrin accumulation which also induces ROS moulding. In both cases, their clinical signs are precipitated by endogenous factors (stress, hormones, low calories intake) and/or exogenous drugs, in particular some anaesthetics. A review of the biochemical and genetic results obtained from patients with different porphyrias, diagnosed at the CIPYP during the last 38 years is presented here, aimed at obtaining additional evidence about the molecular nature of these disorders. The achievements obtained from experimental porphyria models -pharmacologically or genetically induced- are also described, which contributed to the classification of some drugs as prohibited for their use in porphyric patients. Finally, as porphyrins produce ROS and therefore cellular death, they can be used to treat infections by heme-deficient organisms like Trypanosoma cruzi and also as photosensitizers in photodynamic therapy (TFD).

Keywords : Heme metabolism; Porphyrias; Porphyrins; D-aminolevulinic acid; Volatile anaesthetics; Photodynamic therapy; Trypanosoma cruzi.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )